Patent assignee · US · COMPANY

Celator Pharmaceuticals, Inc.

🏢 View company profile →
25Patents
24Active
25Granted
52Portfolio score

Filing activity: Oct 3, 2002 → Feb 17, 2023 · 7 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US7238367B2 Liposome loading with metal ions Human Necessities 57 Expired
US8022279B2 Liposomal formulations of anthracycline agents and cytidine analogs Emerging Cross-Sectional Technologies 48 Active
US7842676B2 Fixed ratio drug combination treatments for solid tumors Human Necessities 47 Active
US7744921B2 Liposome loading with metal ions Human Necessities 46 Active
US8486924B2 Taxane delivery system Chemistry; Metallurgy 44 Active
US8092828B2 Fixed drug ratios for treatment of hematopoietic cancers and proliferative disorders Emerging Cross-Sectional Technologies 42 Active
US8518437B2 Lipid carrier compositions with enhanced blood stability Human Necessities 39 Active
US8431806B2 Liposomal formulations of anthracycline agents and cytidine analogs Emerging Cross-Sectional Technologies 38 Active
US9271931B2 Compositions for delivery of drug combinations Human Necessities 38 Active
US10028912B2 Method of lyophilizing liposomes Human Necessities 38 Active
US10058507B2 Compositions for delivery of drug combinations Human Necessities 37 Active
US7850990B2 Compositions for delivery of drug combinations Human Necessities 37 Active
US10905775B2 Particulate constructs for release of active agents Human Necessities 36 Active
US10166184B2 Method of lyophilizing liposomes Human Necessities 4 Active
US10927418B2 Assays and methods for selecting a treatment regimen for a subject with leukemia Chemistry; Metallurgy 3 Active
US11746386B2 Assays and methods for selecting a treatment regimen for a subject with leukemia Chemistry; Metallurgy 1 Active
US11028076B2 Inhibiting ataxia telangiectasia and Rad3-related protein (ATR) Human Necessities 1 Active
US10835492B2 Method of lyophilizing liposomes Human Necessities 1 Active
US11583544B2 Remote loading of sparingly water-soluble drugs into lipid vesicles Human Necessities 0 Active
US10285951B2 Nanoparticle delivery systems Human Necessities 0 Active
US12370207B2 Low-intensity treatment of hematological disorders Human Necessities 0 Active
US12070471B2 Remote loading of sparingly water-soluble drugs into lipid vesicles Human Necessities 0 Active
US11787781B2 Inhibiting ataxia telangiectasia and RAD3-related protein (ATR) Human Necessities 0 Active
US10722464B2 Compositions for delivery of drug combinations Human Necessities 0 Active
US11413253B2 Nanoparticle delivery systems Human Necessities 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.